Cancer ResearchInherited CDK12 mutations emerge as a hidden driver of early, aggressive prostate cancer
Researchers at the University of British Columbia have identified a rare inherited form of aggressive prostate cancer tied to the CDK12 gene. CDK12 mutations were long thought to arise only spontaneously inside tumors. After analyzing genetic data from more than 4,500 men with aggressive prostate cancer, the team found five unrelated men carrying inherited CDK12 mutations. All five had metastatic disease, diagnosed between ages 44 and 62. Their tumors also showed a distinctive pattern of DNA damage associated with CDK12 loss, which supports a causal role for the inherited mutation. The finding was published in Cancer Discovery. It could eventually expand genetic testing so affected families are identified earlier and screened more closely, when treatment is still possible. The condition is extremely rare, and the numbers are very small, so the findings do not yet show how much risk a carrier faces or whether earlier screening improves outcomes.